Gastrointestinal Cancer News

The 69 NCI–designated cancer centers today endorsed the CDC’s revised guideline that calls for administration of the HPV vaccine in two doses rather than the previously prescribed three-dose series.

An uptake in the number of mammography screenings occurred among various economic subgroups after the Affordable Care Act was implemented in 2011, according to new findings published in Cancer.

The FDA has issued orphan drug designation to CX-4945 for the treatment of cholangiocarcinoma, which will expedite its development, the manufacturer announced.

The number of cancer survivors in the United States is projected to swell from 15.5 million in 2016 to more than 26 million by 2040.

Click here to read the Cover Story, "‘Silver tsunami’ requires ‘all-hands-on-deck’ approach to cancer survivorship"

The American Academy for Cancer Research released the first set of cancer genomic data from Project GENIE, a multiphase, international data-sharing effort.

The two major types of esophageal cancer, esophageal adenocarcinoma and esophageal squamous cell carcinoma, show distinct molecular characteristics and should therefore be approached as separate entities in clinical trials, according to new research published in Nature.

A steady decline in smoking and advances in early detection and treatment have contributed to a 25% reduction in cancer death rates in the United States since 1991, according to Cancer Statistics 2017, the American Cancer Society’s comprehensive annual report on cancer incidence, mortality and survival.

The addition of the investigational drug PEGPH20 to standard first-line chemotherapy significantly prolonged PFS among patients with stage IV metastatic pancreatic cancer, according to study results released by the agent’s manufacturer.

The Fred Hutchinson Cancer Research Center announced the official opening of a first-of-its-kind clinic dedicated to providing cellular-based immunotherapies for patients with cancer.